Nutraceutical mangosteen composition
US6730333B1 · kind B1 · utility
14Cited by
1References
81Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2002 |
| Grant date | May 4, 2004 |
| Priority date | — |
| Expiry date | Oct 30, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nutraceutical compositions derived from the fruit of the Garcinia mangostana L. or mangosteen plant are provided. The nutraceutical mangosteen compositions employ novel combinations of mangosteen fruit pulp and pericarp, and can be additionally complemented by selected juice concentrates to yield a composition for improving general health and wellness in humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.